Upregulation of TRIM11 enhances the growth and migration abilities of MDA-MB-231 cells, and also promotes tumor growth in vivo, while KDM5C activity inhibits tumor progression and rescues the phenotype caused by TRIM11 [138]. The gene discussed is KDM5C; the disease is neoplasm.